KRAS and colorectal carcinoma: To evaluate whether oncogenic KRAS influence the expression of specific AATs, shRNAs targeting KRAS were transfected into KRAS mutant CRC cell lines (SW480, SW620, and HCT116) and determined the changes in the expression and functions of AATs.